2026 Attendees

2027 PROGRAMS

View By:

• Display and Discovery of Biologics
• Engineering Antibodies
• Machine Learning for Protein Engineering

• Antibody-Based Therapies
• Emerging Targets for Oncology & Beyond
• Driving Clinical Success in Antibody-Drug Conjugates

• TS: Intro to Multispecific Antibodies
• Advancing Multispecific Antibodies to the Clinic
• Engineering Bispecific and Multifunctional Antibodies

• Emerging T Cell Engagers
• Advances in Immunotherapy
• Next-Generation Immunotherapies

• Difficult-to-Express Proteins
• Optimizing Protein Expression
• Automating Protein Production Workflows

• ML and Digital Integration in Biotherapeutic Analytics
• Biophysical Methods
• Characterization for Novel Biotherapeutics

• TS: Intro to Immunogenicity
• Predicting Immunogenicity with AI and ML Tools
• TS: Bioassay Development and Analysis

• Biologics for Autoimmune Diseases
• Advances in Immunotherapy
• Emerging Peptide Therapeutics

• ML and Digital Integration in Biotherapeutic Analytics
• Predicting Immunogenicity with AI and ML Tools
• Machine Learning for Protein Engineering